Vimarsana
Biggest News Aggregation in the World

Page 14 - Beta Bionics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beta Bionics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beta Bionics Today - Breaking & Trending Today

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Half-year Report - Vimarsana News

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Half-year Report

Investegate announcements from RTW Venture Fund Ltd, Half-year Report

Beta Bionics Appoints Sean Saint as CEO and Board Member - Vimarsana News

Beta Bionics Appoints Sean Saint as CEO and Board Member

Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational devices limited by Federal (or United States) law to investigational use. Not...

Data supports Beta Bionics' iLet bionic pancreas - Vimarsana News

Data supports Beta Bionics' iLet bionic pancreas

Beta Bionics announced today that a trial of its iLet bionic pancreas met key endpoints, including reduced HbA1c.

Zealand Pharma A/S (OTCMKTS:ZLDPF) and Amadeus IT Group (OTCMKTS:AMADY) Financial Review - Vimarsana News

Zealand Pharma A/S (OTCMKTS:ZLDPF) and Amadeus IT Group (OTCMKTS:AMADY) Financial Review

Zealand Pharma A/S (OTCMKTS:ZLDPF – Get Rating) and Amadeus IT Group (OTCMKTS:AMADY – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability. Risk and Volatility Zealand Pharma A/S has a […]

Bionic Pancreas: Closer to Fully Automated Insulin Delivery? - Vimarsana News

Bionic Pancreas: Closer to Fully Automated Insulin Delivery?

Results from the iLet Bionic Pancreas pivotal trial demonstrate that a system using a novel algorithm for automated insulin delivery may further ease patient burden.